| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Sr VP & Chief Commercial Officer | President, Pharma Pckg Systems
4 companies
Karen Flynn is Director at QTRX and has filed Form 4s across 4 companies. Karen Flynn's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $10.8M at current prices.
The biggest single holding is WST (~$9.6M) as Sr VP & Chief Commercial Officer. The WST filings lean toward selling, a net 58,059 shares.
Karen Flynn has 57 Form 4 filings on record from February 2015 to June 2026, across 4 companies: Director at Stevanato Group S.p.A. (STVN), 2026; Director at Sotera Health (SHC), 2024–2026; Director at QTRX, 2022–2026, and 1 more.
The 73 reported transactions were 49 stock awards, 11 option or other derivative awards, 6 open-market sales and 6 option exercises, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 6 sales worth about $5.0M.
The largest open-market sale was 20,458 shares of WST at an average $116.23 on August 7, 2018, about $2.4M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | STVN Stevanato Group S.p.a. | Director | Sell | 1,493 | $17.09 | $25,515.37 | -20.6% | +28.2% | - | |
| Aug 7, 2018 | WST West Pharmaceutical Services Inc | Sr VP & Chief Commercial Officer | Sale+OE | 20,458 | $116.23 | $2,377,833.34 | -48.7% | - | - | |
| Sep 6, 2016 | WST West Pharmaceutical Services Inc | Sr VP & Chief Commercial Officer | Sell | 14,581 | $83.28 | $1,214,305.68 | -51.9% | - | - | |
| Nov 10, 2015 | WST West Pharmaceutical Services Inc | President, Pharma Pckg Systems | Sale+OE | 18,020 | $63.03 | $1,135,723.11 | -42.3% | - | - | |
| May 22, 2015 | WST West Pharmaceutical Services Inc | President, Pharma Pckg Systems | Sale+OE | 3,091 | $55.24 | $170,736.64 | -11.2% | - | - | |
| May 18, 2015 | WST West Pharmaceutical Services Inc | President, Pharma Pckg Systems | Sale+OE | 1,909 | $55.00 | $104,995.00 | -7.2% | - | - |